Jana Care Aina
Aina is a diagnostic device for smartphones that can analyzes HbA1c, blood glucose, hemoglobin, creatinine, and lipids from a capillary blood sample.
Aina is a diagnostic sensor and smartphone application that plugs into any smartphone and analyzes HbA1c, blood glucose, hemoglobin, creatinine, and lipids from a capillary blood sample in only minutes. The device can be used by patients for self-monitoring as well as by healthcare providers for mass screening and point-of-care testing.
Aina has also developed the Habits Program, based on the landmark Diabetes Prevention Program, to deliver digital coaching and support to patients recently diagnosed with pre-diabetes or type II diabetes.
India, and many low-resource settings, as well as high-resource settings.
Hospitals and health clinics, including Narayana Health Hospital in Bangalore, India.
Aina device: less than 50 USD
Individual tests: Less than 1 USD
The Aina Companion App is free to install on a smartphone.
Goal 3: Good health and well-being.
Patients with diabetes or pre-diabetes and trained professionals
Patients can procure the Jana Care Aina from health clinics and hospitals and download the companion app from the Apple Store. The healthcare workers also use the device to directly test patients.
50,000 patients in India as of February 2017.
The Jana Care Aina Device is a blood glucometer that uses existing colorimetric test strips and plugs into any smartphone via the headphone jack. Blood readings are communicated to an accompanying mobile app, which allows pre-diabetic users to monitor consistently their glucose levels as well as weight, food intake, and physical activity. The product works with iOs and Android devices.
Users may consult distributing health clinics and hospitals with their Jana Care Aina questions.
Single-use test strips can be procured at health clinics and hospitals.
The test strips are single-use. Aida device lifecycle is unknown.
– Early detection for diabetes, pre-diabetes and other chronic diseases
– In point diagnostics and monitoring
– Easy to use
– Low cost
Method comparison to a YSI 2300 analyzer with 750 patient blood samples shows that the Jana Care Aina conforms with accuracy and repeatability requirements specified by ISO 15197:2013 standard (In vitro diagnostic test systems — Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus). Additional test results can be found here.
Clinical validation of the Aina device was performed at the Narayana Health Hospital in Bangalore, India, and AIIMS in Delhi, India.
It is important to make sure hands and device are clean before use in order to prevent infection.
Smartphone, testing strips, the Jana Care Habits app
Goldberger, D., Shreve, E., Siebrecht, W., Pesach, B., Pesach, G., Bitton, G., & Nagar, R. (2009). U.S. Patent No. 7,608,042. Washington, DC: U.S. Patent and Trademark Office.
Clarke, W. L., Cox, D., Gonder-Frederick, L. A., Carter, W., & Pohl, S. L. (1987). Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes care, 10(5), 622-628.
Aina’s accuracy meets ISO15197:2013 regulatory standards needed for CE and US FDA approval.
The device also docks with the Aina Station, a point-of-care platform that can sit in a primary care office or clinic to screen patients with the goal of reduce time that patients have to wait for results from a central lab.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.